• CSE: DTC
  • FSE: DTC
  • USOTC: DTCFF
  • Download our Corporate Deck
  • GER
  • ENG
Defence Therapeutics
  • About Us
    • Our Model
    • Leaders & Partnerships
  • Accum Technology
    • Platform Technology
    • Vaccine Development
  • Investors
  • News
  • Contact
Select Page

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Recent Posts

  • Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million
  • Breakthrough Results: Defences Arm Vaccine Cured 100% of Animals with Pre-established Lymphoma
  • Defence’s Successful Accutox™ Pre-Clinical Efficacy Study Complete Ready for Phase I and Filing
  • USPTO Grants Trademark Registration for Defence Therapeutics®

Recent Comments

    Archives

    • May 2023
    • April 2023

    Categories

    • News Release

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Stock

    CSE: DTC
    FSE: DTC
    USOTC: DTCFF

    Contact

    (514) 947 – 2272
    info@defencetherapeutics.com

    1680 – 200 Burrard Street, Vancouver, BC, V6C 3L6

    Copyright © 2020. Defence Therapeutics. All Rights Reserved. / Web Design by Five Senses Branding